AnaptysBio, Inc. ANAB Advance Future Royalties Liability Noncurrent
Advance Future Royalties Liability Noncurrent at other companies
Other financials
Where this comes from
Reported directly by AnaptysBio, Inc. in its filing.
Tagged under the XBRL concept anab:AdvanceFutureRoyaltiesLiabilityNoncurrent.
The official record: AnaptysBio, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about AnaptysBio, Inc.'s advance future royalties liability noncurrent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AnaptysBio, Inc.'s advance future royalties liability noncurrent?
- AnaptysBio, Inc. (ANAB) reported advance future royalties liability noncurrent of $263.74M in Q1 2026.
- How has AnaptysBio, Inc.'s advance future royalties liability noncurrent changed year-over-year?
- AnaptysBio, Inc.'s advance future royalties liability noncurrent decreased by 20.2% year-over-year, from $330.38M to $263.74M.
- What does advance future royalties liability noncurrent mean?
- This metric represents the long-term portion of obligations arising from upfront payments or financing arrangements received in exchange for future royalty streams on product sales. It reflects the company's commitment to share future revenue with third-party investors or partners beyond the next twelve months. Tracking this liability is essential for assessing the company's long-term revenue retention and the impact of past financing activities on future cash flows.